ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Cytochroma Limited

Cytochroma Limited is an active company incorporated on 19 October 2017 with the registered office located in Roslin, Midlothian. Cytochroma Limited was registered 7 years ago.
Status
Active
Active since incorporation
Company No
SC579331
Private limited company
Scottish Company
Age
7 years
Incorporated 19 October 2017
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 18 October 2024 (11 months ago)
Next confirmation dated 18 October 2025
Due by 1 November 2025 (1 month remaining)
Last change occurred 10 months ago
Accounts
Submitted
For period 1 Nov31 Oct 2023 (12 months)
Accounts type is Unaudited Abridged
Next accounts for period 31 October 2024
Due by 31 October 2025 (1 month remaining)
Contact
Address
Roslin Innovation Centre Roslin Innovation Centre
Easter Bush Campus
Edinburgh
EH25 9RG
Scotland
Address changed on 9 May 2024 (1 year 4 months ago)
Previous address was 90/4 Constitution Street Edinburgh EH6 6RP Scotland
Telephone
Unreported
Email
Unreported
People
Officers
2
Shareholders
31
Controllers (PSC)
1
Director • Scottish • Lives in UK • Born in Nov 1985
Director • Chairman • British • Lives in United States • Born in Mar 1957
Dr Katherine Rachel Cameron
PSC • Scottish • Lives in UK • Born in Nov 1985
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Brands
Cytochroma Limited
Cytochroma Limited develops human iPSC cell models to predict clinical outcomes, offering protocols and models for consistent results.
Financials
Net Assets, Total Assets & Total Liabilities (2018–2023)
Period Ended
31 Oct 2023
For period 31 Oct31 Oct 2023
Traded for 12 months
Cash in Bank
£687
Decreased by £52.21K (-99%)
Turnover
Unreported
Same as previous period
Employees
2
Decreased by 6 (-75%)
Total Assets
£51.04K
Decreased by £138.57K (-73%)
Total Liabilities
-£144.21K
Increased by £6.88K (+5%)
Net Assets
-£93.17K
Decreased by £145.45K (-278%)
Debt Ratio (%)
283%
Increased by 210.11% (+290%)
Latest Activity
Confirmation Submitted
10 Months Ago on 23 Oct 2024
Dr Kate Cameron Details Changed
11 Months Ago on 10 Oct 2024
Abridged Accounts Submitted
1 Year 3 Months Ago on 3 Jun 2024
Registered Address Changed
1 Year 4 Months Ago on 9 May 2024
Tariq Rafique Resigned
1 Year 5 Months Ago on 8 Apr 2024
Dr Richard Eglen Appointed
1 Year 5 Months Ago on 1 Apr 2024
Confirmation Submitted
1 Year 10 Months Ago on 31 Oct 2023
Full Accounts Submitted
2 Years 5 Months Ago on 24 Mar 2023
Dr Kate Cameron (PSC) Details Changed
2 Years 6 Months Ago on 22 Feb 2023
Margaret Temple Resigned
2 Years 10 Months Ago on 11 Nov 2022
Get Credit Report
Discover Cytochroma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 18 October 2024 with updates
Submitted on 23 Oct 2024
Director's details changed for Dr Kate Cameron on 10 October 2024
Submitted on 23 Oct 2024
Unaudited abridged accounts made up to 31 October 2023
Submitted on 3 Jun 2024
Registered office address changed from 90/4 Constitution Street Edinburgh EH6 6RP Scotland to Roslin Innovation Centre Roslin Innovation Centre Easter Bush Campus Edinburgh EH25 9RG on 9 May 2024
Submitted on 9 May 2024
Termination of appointment of Tariq Rafique as a director on 8 April 2024
Submitted on 9 May 2024
Appointment of Dr Richard Eglen as a director on 1 April 2024
Submitted on 5 Apr 2024
Statement of capital following an allotment of shares on 16 November 2023
Submitted on 16 Nov 2023
Confirmation statement made on 18 October 2023 with no updates
Submitted on 31 Oct 2023
Total exemption full accounts made up to 31 October 2022
Submitted on 24 Mar 2023
Change of details for Dr Kate Cameron as a person with significant control on 22 February 2023
Submitted on 22 Feb 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year